{{Rsnum
|rsid=6726395
|Gene=NFE2L2
|Chromosome=2
|position=177238501
|Orientation=plus
|GMAF=0.4518
|Gene_s=NFE2L2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 24.8 | 42.5 | 32.7
| HCB | 16.8 | 42.3 | 40.9
| JPT | 9.7 | 36.3 | 54.0
| YRI | 36.1 | 53.7 | 10.2
| ASW | 36.8 | 52.6 | 10.5
| CHB | 16.8 | 42.3 | 40.9
| CHD | 11.9 | 51.4 | 36.7
| GIH | 7.9 | 37.6 | 54.5
| LWK | 34.5 | 50.0 | 15.5
| MEX | 10.3 | 46.6 | 43.1
| MKK | 42.3 | 45.5 | 12.2
| TSI | 21.6 | 52.9 | 25.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=21774808
|Title=An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study
|OA=1
}}

{{PMID Auto
|PMID=19671143
|Title=Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.
|OA=1
}}

{{PMID Auto
|PMID=20196834
|Title=Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease.
|OA=1
}}

{{PMID Auto
|PMID=23276910
|Title=Association between polymorphism of the NQO1, NOS3 and NFE2L2 genes and AMD
}}

{{PMID Auto
|PMID=24528044
|Title=Association of NRF2 Polymorphism with Cholangiocarcinoma Prognosis in Thai Patients
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}